| Financial Year |
December 31 2020 |
| Monetary Funds |
22,558,866.16 |
| Held-for-trading Financial Assets |
7,172,870.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
666,807,425.30 |
| Advances to Suppliers |
4,647,731.74 |
| Other Receivables |
11,775,269.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
356,474,622.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,344,746.08 |
| Total Current Assets |
1,081,781,530.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,773,269.33 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
516,404,480.43 |
| Under-construction Projects |
37,704,511.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
46,602,133.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,255,965.74 |
| Deferred Income Tax Assets |
17,335,524.51 |
| Other Non-Current Assets |
1,196,435.00 |
| Sub-Total of Non-Current Assets |
626,272,320.18 |
| Total Assets |
1,708,053,850.56 |
| Short-Term Loans |
153,303,843.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
759,121,154.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,289,482.25 |
| Taxes Payable |
10,146,185.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,725,920.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,394,882.89 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
953,981,469.75 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,936,250.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,917,406.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
73,847,658.48 |
| Total Liabilities |
1,027,829,128.23 |
| Paid-In Capital(Or Share Stock) |
99,000,000.00 |
| Capital Surplus |
235,655,498.20 |
| Surplus Reserve |
9,613,523.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
336,012,445.49 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
680,224,722.33 |
| Owner's Equity（Stockholder's Equity） |
680,224,722.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,708,053,850.56 |
